{
  "retracted": false,
  "timestamp": 1538697600000,
  "updates": [
    {
      "timestamp": 1580210651063,
      "identifier": {
        "doi": "10.1038/s41591-018-0235-z"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41591-018-0053-3"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma"
}
